Scripps Institute Spin-Out Company Raises $3 Million
UF startup Myosin Therapeutics, a biotechnology company developing medications to treat brain cancer and methamphetamine addiction, secured $3 million in seed funding.
UF startup Myosin Therapeutics, a biotechnology company developing medications to treat brain cancer and methamphetamine addiction, secured $3 million in seed funding.